Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours
Clinical trial NCT05114668 · COMPLETED
Trial details
- NCT number
- NCT05114668
- Sponsor
- Kazia Therapeutics Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2024-11-04
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.